Non-Cutaneous Melanoma — Trials

Non-Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

312 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 87
Recruiting: 44
Ph III recruiting: 6
Growth YoY: —
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 151–167 of 167 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00031733	Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma	completed	Phase 2	60	University of Southern CaliforniaOTHER	1	May 22, 2014	clinicaltrials
NCT00085189	Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma	completed	Phase 2	42	University of Southern CaliforniaOTHER	1	May 22, 2014	clinicaltrials